Showing results (271-280 of 323) with videos related to
Sort By:
Pageof 33
Journal for Immunotherapy of Cancer|November 24, 2021
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS studySara Lonardi, Alessandra Anna Prete, Federica Morano, et al.ESMO Open|July 19, 2018
TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable <i>RAS</i> and <i>BRAF</i> wild-type metastatic colorectal cancerBeatrice Borelli, Roberto Moretto, Sara Lonardi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
Molecular lineages of sporadic mismatch-repair deficient colorectal cancerMichael B Foote, Guilherme Harada, Somer Abdelfattah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric CancerFilippo Pietrantonio, Rosalba Miceli, Alessandra Raimondi, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World StudyMonica Niger, Margherita Rimini, Florian Castet, et al.Cell Death and Differentiation|May 8, 2021
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatmentSafae Terrisse, Lisa Derosa, Valerio Iebba, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled AnalysisAlessandra Raimondi, Gabriele Tinè, Alexej Ballhausen, et al.JAMA Oncology|August 12, 2021
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE TrialErika Martinelli, Giulia Martini, Vincenzo Famiglietti, et al.Cancer Medicine|December 2, 2024
Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic CancerFederico Nichetti, Marco Silvestri, Luca Agnelli, et al.Tumori|June 12, 2020
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-SMaria Di Bartolomeo, Alessandra Raimondi, Fabiola Cecchi, et al.Pageof 33